6 research outputs found

    GLUCAGONOMA SYNDROME-A CASE REPORT

    Get PDF
    ABSTRACT : The glucagonoma syndrome is characterized by dermatitis, glucose intolerance, hypoaminoacidemia, and hyperglucagonemia secondary to an alpha-cell tumor of the pancreas. The classical symptoms are associated with alpha-cell pancreatic islet cell tumor or 'glucagonoma'. Other clinical features include anemia, glossitis, and weight loss. A 65-year-old woman with the syndrome came for medical attention for a skin rash, glossitis, and weight loss. A skin biopsy was suggestive of necrolytic migratory erythema. Necrolytic migratory erythema is considered to be a paraneoplastic dermatosis. To our knowledge, it is rarely reported in the literature. Skin symptoms are important; often they are the clue to the diagnosis of glucagonoma syndrome. On ultrasound there was hypoechoic mass in the distal pancreas so she was advised CT scan of the mass. CT scan showed high density area 4.5 cms in diameter with calcification in the tail of the pancreas. She later on passed away because of late presentation, delayed diagnosis and delayed treatment. The diagnosis of necrolytic migratory erythema is a matter of great importance, since it might be an auxiliary tool for the early detection of glucagonoma

    Predicting the pathogenicity of novel variants in mitochondrial tRNA with MitoTIP.

    No full text
    Novel or rare variants in mitochondrial tRNA sequences may be observed after mitochondrial DNA analysis. Determining whether these variants are pathogenic is critical, but confirmation of the effect of a variant on mitochondrial function can be challenging. We have used available databases of benign and pathogenic variants, alignment between diverse tRNAs, structural information and comparative genomics to predict the impact of all possible single-base variants and deletions. The Mitochondrial tRNA Informatics Predictor (MitoTIP) is available through MITOMAP at www.mitomap.org. The source code for MitoTIP is available at www.github.com/sonneysa/MitoTIP

    Separation of benign and pathogenic variants by MitoTIP.

    No full text
    <p>(A) Pathogenicity scores from naïve evaluations of known pathogenic (n = 38) and described benign (n = 651) variants plotted using box and whiskers at 5–95% (<i>p</i><0.0001 by Mann Whitney test). Negative scoring is possible when polymorphisms improve Watson-Crick pairing in stems. (B) Sensitivity and specificity plot of these data at a range of pathogenicity scores. The crossover pathogenicity score was 12.8.</p

    Position and stem penalties for pathogenicity prediction.

    No full text
    <p>(A) The variant history and conservation scores at the analogous positions of every mitochondrial tRNA were averaged and used to score a generic tRNA structure. This identifies the regions of the tRNA that are most vulnerable to pathogenic variants. (B) Variants at base pairing regions are assessed based on the steric hindrance they induce, with the highest scores assigned at the ends of the stems region as shown in the scoring heat map for the phenylalanine tRNA.</p
    corecore